You may have noticed: Mortgage rates are spiking. From a low of 3.34% earlier this year, the average 30-year mortgage now runs 3.81%. Most of that gain came in the last week.
What's going on? It's likely a combination of two things. Federal Reserve chairman Ben Bernanke hinted last week that the Fed may begin tapering its "quantitative easing" policies sooner than some imagined.There also seems to be a general sense that the economy is getting better. That pushes investors away from safe assets like mortgages and toward riskier ones like stocks.
The common reaction to rising mortgage rates is to wonder whether it will sting the housing market. Indeed, it may. But you have to keep perspective. Mortgage rates are rising from absurdly low rates. The "spike" of the last week brings interest rates back all the way to where they were less than a year ago. In context of the last 30 years, the rise is barely noticeable:
Source: Federal Reserve.
Top 10 Growth Stocks To Buy Right Now: iShares Transportation Average ETF (IYT)
iShares Dow Jones Transportation Average Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones Transportation Average Index (the Index). The Index measures the performance of the transportation sector of the United States equity market, and includes companies in primary groups, such as airlines, trucking, railroads, air freight, transportation services and industrial services.
The Index is subset of the Dow Jones U.S Total Market Index. The components stocks are weighted based on the price of the component securities, with the highest priced securities generally having higher weighting in the Index. The Index is adjusted to reflect changes in capitalization resulting from mergers, acquisitions, stock rights, substitutions and other capital events. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Chad Fraser] 2013 was a strong year for railroad stocks: the iShares Transportation ETF (NYSE: IYT), about the closest you can get to a gauge for the industry (roughly 30% of the fund’s portfolio is devoted to railway operators) gained 39% during the year.
That’s miles ahead of the Dow Jones Industrials (up 26%) and the S&P 500 (up 29%).
10 Best Industrial Disributor Stocks To Watch For 2015: Agent155 Media Corp (AGMC)
Agent155 Media Corp., formerly Freshwater Technologies Inc., incorporated on December 10, 1999, is a development-stage company. It will offer a free, online presence for the global artistic and athletic communities through its Website, Agent155.com. Agent155.com provides fashion, performer, art, sports, music, film, writer professionals and amateurs a multi-media content management solution, enabling a collaborative forum to network and develop through www.agent155.com. It also provides talent agencies, agents, producers, directors, and recording companies a location to search and view the profiles. It also re-distributes member content through traditional media channels, such as television, radio, film and print. It will produce films, music tours, commercials, and various events using talent from Agent155.com.directors, and recording companies a location to search and view the profiles and work of talent. In addition, the Company will provide targeted advertising opportunities for members and businesses.
Agent155 Media Corp fulfills the role of a matchmaker allowing talented individuals direct access to those who seek specific talents. Agent155 Media Corp provides talent agencies, agents, producers, directors and recording companies a location to search and view pool of profiles and work of talent.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Profitable Developments Inc (OTCMKTS: PRDL), Dynamic Applications Corp (OTCMKTS: DYAP) and Agent155 Media Corp (OTCMKTS: AGMC) have been getting some attention lately in various investment newsletters. One of these small caps has been getting attention thanks to paid promotions while another saw a trading volume spike for the first three days of last week and the last one has seen a steady rise in share price over October. So what�� going on with these small cap stocks? Here is a quick reality check to help you decide how hot they might be or become:
10 Best Industrial Disributor Stocks To Watch For 2015: ARIAD Pharmaceuticals Inc.(ARIA)
ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company?s lead cancer product, ridaforolimus is being studied in multiple clinical trials in patients with various types of cancers, including metastatic sarcomas, breast cancer, endometrial cancer, prostate cancer, and non-small cell lung cancer. Its product pipeline also includes ponatinib, a pan BCR-ABL inhibitor in phase 2 clinical trial for applications in various hematological cancers and solid tumors; and AP26113, an anaplastic lymphoma kinase inhibitor in preclinical studies for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma. In addition, the company focuses on a drug discovery program centered on small-molecule therapies that are molecularly targeted to cell-signaling pathways implicated in cancer. Further, it licenses its ARGENT cell-sign aling regulation technologies to pharmaceutical and biotechnology companies to develop and commercialize therapeutic products, and to conduct drug discovery research. The company has collaboration and license agreements with Merck & Co., Inc. for the development, manufacture, and commercialization of ridaforolimus; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus to prevent restenosis of injured vessels. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By Monica Gerson]
Ariad Pharmaceuticals (NASDAQ: ARIA) surged 9.76% to $4.16 in the pre-market session. Sarissa Capital Management LP has taken a 6.22% stake in Ariad Pharmaceuticals.
- [By Ben Levisohn]
And save a spot in your hearts Tower Group International (TWGP), which dropped an S&P-1500 worst 41% after the insurer had to set aside far more cash to cover losses than investors had expected, and Ariad Pharmaceuticals (ARIA), which plunged 78% after the FDA halted one of its drug trials because the medicine in question was too dangerous. They serve as a reminder that no matter the shenanigans among politicians, fundamentals will almost always have the last say.
- [By Bryan Murphy]
In a perfect world, a stock would always - and accurately - reflect all the information known (and/or presumed) about a particular company. We don't live or trade in a perfect world though. In the real world, a stock's value is forever changing, caught between a fear and greed cycle that may or may not jive with a reasonable perception of the company's worth. That's not necessarily a bad thing, however, as you can use that ongoing volatility to your advantage. Enter Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). Anybody who was mulling an position in ARIA needs to know that a pretty persistent technical pattern has developed, and though it may not look red hit right now, that's the perfect time to wade in.
- [By Jayson Derrick]
Ariad Pharmaceutical (NASDAQ: ARIA) saw its shares surge 35.13 percent following positive comments from European Regulators that will allow the company to continue selling its Iclusig drug. Shares closed at $3.77, well off its 52 week highs of $24.59
10 Best Industrial Disributor Stocks To Watch For 2015: First Horizon National Corp (FHN)
First Horizon National Corporation (FHN), incorporated in 1968, is a bank holding company. The Company provides financial services through its subsidiary, First Tennessee Bank National Association (the Bank), and its subsidiaries. The Company�� two brands First Tennessee and FTN Financial provide customers with a range of products and services. First Tennessee provides retail and commercial banking services throughout Tennessee. FTN Financial (FTNF) is engaged in fixed income sales, trading, and strategies for institutional clients in the United States and abroad. FHN has four operating business segments: regional banking, capital markets, corporate, and non-strategic. As of December 31, 2011, the Bank had $16.4 billion in total deposits and $16 billion in total net loans. As of December 31, 2011, the Company�� subsidiaries had over 200 business locations in 17 the United States states, Hong Kong, and Tokyo, excluding off-premises automated teller machines (ATMs). As of December 31, 2011, the Bank had 183 branch locations in four states, which include 172 branches in metropolitan areas of Tennessee; two branches in northwestern Georgia; seven branches in northwestern Mississippi, and two branches in North Carolina. As of December 31, 2011, FTN Financial products and services were offered through 18 offices in total, including 16 offices in 14 states plus an office in each of Hong Kong and Tokyo.
The regional banking segment offers financial products and services, including traditional lending and deposit taking, to retail and commercial customers in Tennessee and surrounding markets. Regional banking provides investments, financial planning, trust services and asset management, credit card, cash management, and first lien mortgage originations within the Tennessee footprint. In addition, the regional banking segment includes correspondent banking, which provides credit, depository, and other banking related services to other financial institutions.
The capital markets se! gment consists of fixed income sales, trading, and strategies for institutional clients in the United States and abroad, as well as loan sales, portfolio advisory, and derivative sales. The corporate segment consists of gains on the extinguishment of debt, unallocated corporate expenses, expense on subordinated debt issuances and preferred stock, bank-owned life insurance, unallocated interest income associated with excess equity, net impact of raising incremental capital, revenue and expense associated with deferred compensation plans, funds management, low income housing investment activities, and charges related to restructuring, repositioning, and efficiency. The non-strategic segment consists of the wind-down national consumer lending activities, legacy mortgage banking elements, including servicing fees, and the associated ancillary revenues and expenses related to these businesses. Non-strategic also includes the wind-down trust preferred loan portfolio and exited businesses along with the associated restructuring, repositioning, and efficiency charges.
As of December 31, 2011, the Company provided services through its subsidiaries, which include general banking services for consumers, businesses, financial institutions, and governments; through FTN Financial fixed income sales and trading, underwriting of bank, loan sales, advisory services and derivative sales; discount brokerage and full-service brokerage; correspondent banking; transaction processing, such as nationwide check clearing services and remittance processing; trust, fiduciary, and agency services; credit card products; equipment finance; investment and financial advisory services; mutual fund sales as agent; retail insurance sales as agent, and mortgage banking services.
As of December 31, 2011, the commercial, financial, and industrial (C&I) portfolio was eight billion dollars, and is consisted of loans used for general business purposes, and consisted of relationship customers in Tennessee and certain n! eighborin! g states, which are managed within the regional bank. Products include working capital lines of credit, term loan financing of owner-occupied real estate and fixed assets, and trade credit enhancement through letters of credit. As of December 31, 2011, the unpaid principal balance (UPB) of trust preferred loans totaled $447.2 million with the UPB of other bank-related loans totaling approximately $161.8 million. The commercial real estate portfolio includes both financings for commercial construction and non-construction loans. This portfolio is segregated between income commercial real estate (CRE) loans which contain loans, lines, and letters of credit to commercial real estate developers for the construction and mini- permanent financing of income-producing real estate, and residential CRE loans. The residential CRE portfolio includes loans to residential builders and developers for the purpose of constructing single-family detached homes, condominiums, and town homes. As of December 31, 2011, the residential CRE portfolio was $.1 billion. As of December 31, 2011, the consumer real estate portfolio was $5.3 billion, and is composed of home equity lines and installment loans. As of December 31, 2011, the credit card and other portfolios were $.3 billion, and primarily include credit card receivables, automobile loans, and over-the-counter (OTC) construction loans and other consumer related credits.
FHN�� investment portfolio consists of debt securities, including government agency issued mortgage-backed securities (MBS) and government agency issued collateralized mortgage obligations (CMO). During the year ended December 31, 2011, Government agency issued MBS and CMO, and other agencies averaged $2.9 billion. During 2011, the United States treasury securities and municipal bonds averaged $79.5 million. During 2011, investments in equity securities averaged $222.3 million.
During 2011, short-term funds (certificates of deposit greater than $100,000, federal funds purchased (! FFP), sec! urities sold under agreements to repurchase, trading liabilities, and other short-term borrowings) averaged $3.6 billion. During 2011, other borrowings increased to $.3 billion. Term borrowings include senior and subordinated borrowings and advances with original maturities greater than one year. During 2011, average term borrowings averaged $2.6 billion.
The Company competes with Regions Bank, SunTrust Bank, Wells Fargo Bank N.A., Bank of America N.A., and Pinnacle National Bank.
Advisors' Opinion:- [By Sean Williams]
Finally, regional bank First Horizon National (NYSE: FHN ) , which has banking branches throughout Tennessee, added 4.2% just a day after paying shareholders a $0.05 quarterly dividend. Like Genuine Parts, there is no company specific news driving First Horizon higher, but the prospect for a higher net interest margin because of higher interest rates is certainly adding a boost to banks like First Horizon that rely on traditional loan and deposit growth. But as my Foolish colleague John Maxfield recently pointed out, you may want to keep your expectations for First Horizon tempered in the interim.
- [By Monica Gerson]
First Horizon National (NYSE: FHN) is estimated to report its Q3 earnings at $0.18 per share on revenue of $307.14 million.
Laboratory Corp. of America Holdings (NYSE: LH) is expected to report its Q3 earnings at $1.80 per share on revenue of $1.45 billion.
10 Best Industrial Disributor Stocks To Watch For 2015: Insmed Inc.(INSM)
Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company primarily focuses on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Its lead product candidate includes ARIKACE, an inhaled antibiotic supported by positive phase 2 results for treating serious lung infections due to susceptible bacteria. The U.S. Food and Drug Administration has cleared the company's investigational new drug application to conduct a pivotal Phase 3 clinical trial of ARIKACE in nontuberculous mycobacteria lung infections. Insmed Incorporated was founded in 1999 and is based in Monmouth Junction, New Jersey.
Advisors' Opinion:- [By Luke Jacobi]
Insmed (NASDAQ: INSM) gained 8.21 percent to $14.11 after the company closed enrollment of Phase 2 clinical trial of ARIKACE.
Molycorp (NYSE: MCP) dropped 21.41 percent to $5.58 after the company announced its plans to sell $200 million in shares.
- [By Eric Volkman]
Insmed (NASDAQ: INSM ) will have nearly $60 million at its disposal if a new public stock offering goes as planned. The company is floating 6 million shares of its common stock in a public issue that has been priced at $10.40 per share. The gross take will be $62.4 million, which the firm said should net it around $58 million after fees and expenses.
10 Best Industrial Disributor Stocks To Watch For 2015: Polydex Pharmaceuticals Ltd (POLXF.PK)
Polydex Pharmaceuticals Limited, incorporated on June 14, 1979, is engaged in the research, development, manufacture and marketing of biotechnology-based products for the human pharmaceutical market. The Company also manufactures bulk pharmaceutical intermediates for the global veterinary pharmaceutical industry. It focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The products of the Company include Iron Dextran and Dextran Sulphate. The wholly owned subsidiaries of the Company include Dextran Products Limited (Dextran Products) and Chemdex Inc (Chemdex).
Iron Dextran
Iron Dextran is a derivative of Dextran produced by complexing iron with Dextran. Iron Dextran is injected into pigs at birth as a treatment for anemia. The Company sells Iron Dextran to independent distributors and wholesalers in Europe, the Far East and Canada. Chemdex, Inc. has United States FDA approval for the manufacture and sale of Iron Dextran for veterinary use.
Dextran Sulphate
Dextran Sulphate is a specialty chemical derivative of Dextran used in research applications by the pharmaceutical industry and other centers of chemical research. Dextran Sulphate manufactured by the Company is sold primarily to independent distributors and wholesalers in the United States and Europe as analytical chemical applications.
Advisors' Opinion:- [By The GeoTeam]
Polydex Pharmaceuticals (POLXF.PK) Limited, through its subsidiaries, engages in the development, manufacture, and marketing of biotechnology-based products for the human pharmaceutical market. It is also involved with manufacture of bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It primarily offers Dextran and Dextran derivative products.
10 Best Industrial Disributor Stocks To Watch For 2015: Enpro Industries (NPO)
EnPro Industries, Inc. designs, develops, manufactures, and markets engineered industrial products primarily in the United States and Europe. The company operates through three segments: Sealing Products, Engineered Products, and Engine Products and Services. The Sealing Products segment provides metallic, non-metallic, and composite material gaskets; dynamic seals; compression packing; resilient metal seals; elastomeric seals; expansion joints; heavy-duty truck wheel-end component systems, including brake products; flange sealing and isolation products; pipeline casing spacers/isolators; casing end seals; sealing systems for sealing pipeline penetrations; hole forming products; manhole infiltration sealing systems; safety-related signage for pipelines; bellows and bellow assemblies; pedestals for semiconductor manufacturing; polytetrafluoroethylene products; and sheeted rubber products. Its products are used in various industries, including chemical and petrochemical proc essing, petroleum extraction and refining, pulp and paper processing, heavy-duty trucking, power generation, food and pharmaceutical processing, primary metal manufacturing, mining, water and waste treatment, aerospace, medical, filtration, and semiconductor fabrication. The Engineered Products segment offers bearing products and aluminum bushing blocks for use in automotive, pump and compressor, construction, power generation, and general industrial markets; and components for reciprocating compressors and engines in refining, petrochemical, natural gas gathering, and storage and transmission markets. The Engine Products and Services segment manufactures, sells, and services heavy-duty, medium-speed diesel, natural gas, and dual fuel reciprocating engines for shipyards, municipal utilities, institutional and industrial organizations, sewage treatment plants, nuclear power plants, and offshore oil and gas platforms. The company was founded in 2002 and is headquartered in Cha rlotte, North Carolina.
Advisors' Opinion:- [By Lisa Levin]
EnPro Industries (NYSE: NPO) shares rose 25.20% to $74.13. The volume of EnPro Industries shares traded was 2661% higher than normal. EnPro's Garlock won a trial on Asbestos liability. CL King upgraded the stock from Neutral to Buy.
No comments:
Post a Comment